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Cat scratch fever (also known as cat scratch disease and bartonellosis) is an
infectious disease caused by the proteobacterium Bartonella henselae following
a cat scratch. Although the infection usually resolves spontaneously without
treatment in healthy adults, bartonellosis may lead to severe complications in
young children and immunocompromised patients, and there is new evidence
suggesting that B. henselae may be associated with a broader range of clinical
symptoms then previously believed. The genome of B. henselae contains genes
for two putative Nudix hydrolases, BH02020 and BH01640 (KEGG). Nudix
proteins play an important role in regulating the intracellular concentration of
nucleotide cofactors and signaling molecules. The amino-acid sequence of
BH02020 is similar to that of the prototypical member of the Nudix superfamily,
Escherichia coli MutT, a protein that is best known for its ability to neutralize
the promutagenic compound 7,8-dihydro-8-oxoguanosine triphosphate. Here,
the crystal structure of BH02020 (Bh-MutT) in the Mg
2+-bound state was
determined at 2.1 A ˚ resolution (PDB entry 3hhj). As observed in all Nudix
hydrolase structures, the  -helix of the highly conserved ‘Nudix box’ in
Bh-MutTis one of two helices that sandwich a four-stranded mixed  -sheet with
the central two  -strands parallel to each other. The catalytically essential
divalent cation observed in the Bh-MutT structure, Mg
2+, is coordinated to
the side chains of Glu57 and Glu61. The structure is not especially robust; a
temperature melt obtained using circular dichroism spectroscopy shows that
Bh-MutTirreversibly unfolds and precipitates out of solution upon heating, with
a Tm of 333 K.
1. Introduction
Cat scratch fever (also known as cat scratch disease and bartonell-
osis) is a bacterial infection characterized by a bump or blister at the
original site of entry, swollen lymph nodes, headaches and overall
general discomfort. The etiological agents responsible for the disease
are bacteria from the fastidious hemotropic Gram-negative genus
Bartonella (Chomel & Kasten, 2010). This genus contains 19 species,
of which six have been associated with the human disease (Florin et
al., 2008). Of these six species, B. henselae is the primary agent
responsible for cat scratch fever. As the name of the disease suggests,
the chief reservoir for B. henselae is the domestic cat, with the
bacteria being transmitted to humans primarily via scratches (Florin
et al., 2008). It is debatable whether cats themselves become ill owing
to B. henselae infection (Chomel et al., 1996). There is no horizontal
transfer of B. henselae between cats; instead, inter-feline spread of
B. henselae occurs through a vector, Ctenocephalides felix, the cat ﬂea
(Chomel et al., 1996). It was generally believed that the infection did
not require medical treatment, except in immunocompromised indi-
viduals, including those with human immunodeﬁciency virus infec-
tions. However, as techniques to diagnosis the presence of B. henselae
have improved, there is a new concern that it may be responsible for
a broader range of clinical symptoms, including prolonged fever of
unknown origin (Florin et al., 2008). Owing to the widening spectrum
of B. henselae infections and the widespread presence of B. henselaein the domestic cat, there is a renewed interest in understanding the
biochemistry of B. henselae and in developing new therapies to
combat this organism.
The genome of B. henselae contains genes for two putative Nudix
hydrolases, BH02020 and BH01640 (KEGG). The Nudix superfamily
of proteins (Pfam PF00293) is large, with over 16 000 members as of
the end of 2010, and widely distributed, with members identiﬁed
in organisms as diverse as viruses and humans (McLennan, 2006).
Associated with their wide distribution is an ability to act, primarily
as polyphosphate pyrophosphohydrolases (Bessman et al., 1996), on a
wide range of substrates of the general structure shown in Fig. 1. It is
from this general structure, Nucleoside diphosphates linked to some
other moiety x, that the acronym ‘Nudix’ arose (Abeygunawardana et
al., 1995; Bessman et al., 1996). Identiﬁed Nudix substrates include
capped mRNA (Wang, Jiao et al., 2002), dinucleotide coenzymes,
nucleotide sugars, nucleotide alcohols, dinucleotide polyphosphates,
both canonical and oxidized (deoxy)ribonucleoside triphosphates
(NTPs) (Dunn et al., 1999) and canonical (deoxy)ribonucleoside
diphosphates (NDPs) (Fisher et al., 2004; Buchko et al., 2008). Some
Nudix substrates have been reported without a nucleoside, such as
thiamine pyrophosphate (Lawhorn et al., 2004), diphosphoinositol
polyphosphates (Safrany et al., 1998) and dihydroneopterin triphos-
phate (Klaus et al., 2005). With a few exceptions, catalysis depends on
a highly conserved sequence of amino acids, GX5EX7REUXEEXGU
(where U is an aliphatic and hydrophobic amino acid and X is any
amino acid), called the ‘Nudix box’ (Abeygunawardana et al., 1995;
Bessman et al., 1996). This box forms a loop–helix–loop structural
motif that is part of the larger substrate-binding Nudix fold. Glutamic
acid residues in the core of the Nudix box, REUXEE, bind one to
three divalent cations, and at least one cation is required for hydro-
lase activity. While Nudix hydrolases can bind a number of different
divalent cations, including Mn
2+ and Co
2+ (Lin et al., 1997; Buchko et
al., 2008), the highest activity observed in vitro is usually with Mg
2+,
the cation that is most likely to be relevant under physiological
conditions (Bessman et al., 1996). Detailed features of the Nudix fold,
a mixed  -sheet sandwiched between the catalytic  -helix of the
Nudix box and a second  -helix, confer the substrate speciﬁcity of
Nudix hydrolases (Mildvan et al., 2005; McLennan, 2006). By
hydrolyzing their substrates, Nudix proteins effect the elimination of
potentially toxic endogenous nucleotides from the cell and regulate
the concentration of nucleotide cofactors and signaling molecules
inside the cell (Bessman et al., 1996; Galperin et al., 2006). For
example, Escherichia coli MutT protein, the prototypical member of
the Nudix superfamily, preferably hydrolyzes 7,8-dihydro-8-oxo-
guanosine triphosphate, a promutagenic compound that is generated
during normal cellular metabolism and upon exposure to oxidative
stress (Grollman & Moriya, 1993), into nonmutagenic nucleoside
monophosphate and inorganic phosphate (Maki & Sekiguchi, 1992;
Weber et al., 1992). Given the important housekeeping duties
performed by Nudix hydrolases, the crystal structure of one of the
two Nudix hydrolases present in the genome of B. henselae, BH02020
(Bh-MutT), was solved and its structure described in relation to other
Nudix protein structures.
2. Materials and methods
2.1. Cloning, expression and purification
The Bh-MutT gene (BH02020/YP_033055.1; NCBI) was ampliﬁed
using the genomic DNA of B. henselae strain Houston-1 and the
oligonucleotide primers 50-GGGTCCTGGTTCGATGCCTATAAA-
AAGTTCACTTCTTATT-30 (forward) and 50-CTTGTTCGTG-
CTGTTTATTAAATAAAGAAATTTTTTAATACCTGAACTA-30
(reverse) (Invitrogen, Carlsbad, California, USA). The ampliﬁed
Bh-MutT gene was then inserted into NruI/PmeI-digested expression
vector AVA0421 by ligation-independent cloning at a site that
provided a 21-residue tag (MAHHHHHHMGTLEAQTQGPGS–)
at the N-terminus of the expressed protein (Choi et al., 2011). The
recombinant plasmid was transformed into E. coli BL21(DE3)-R3-
pRARE2 cells (a gift from SGC-Toronto, Toronto, Ontario, Canada)
via a heat-shock method and the resulting clone was used to inoculate
2 l of autoinduction medium (Studier, 2005) in a LEX bioreactor
(Harbinger Biotechnology and Engineering Corporation, Markam,
Ontario, Canada). After 72 h of growth at 293 K, the cells were
harvested, ﬂash-frozen in liquid nitrogen and stored at 193 K.The cell
pellet was subsequently solubilized in 200 ml lysis buffer (25 mM
HEPES, 500 mM NaCl, 5% glycerol, 30 mM imidazole, 0.5%
CHAPS, 10 mM MgCl2,1 m M TCEP, 1 mM AEBSF, pH 7.0)
containing 10 mg lysozyme and sonicated for 30 min. After sonica-
tion, samples were treated with Benzonase (500 units) and centri-
fuged for 1 h (14 000 rev min
 1 in a Sorvall SLA-1500 rotor) to
remove cell debris. The protein was puriﬁed by immobilized metal-
ion afﬁnity chromatography on a 5 ml HisTrap FF Nickel Sepharose
column (GE Healthcare, Piscataway, New Jersey, USA) using an
A ¨TKAexplorer (GE Healthcare, Piscataway, New Jersey, USA).
Fractions containing Bh-MutTwere pooled, concentrated and further
puriﬁed by size-exclusion chromatography on a Superdex75 HiLoad
26/60 column (GE Healthcare, Piscataway, New Jersey) that also
exchanged the protein into crystallization buffer (25 mM HEPES,
500 mM NaCl, 5% glycerol, 2 mM dithiothreitol, 0.025% sodium
azide pH 7.5). Fractions containing Bh-MutT were pooled and con-
centrated (Amicon Ultra-15 with a 3000 Da MWCO) to 27 mg ml
 1.
Protein samples were aliquoted in 100 ml volumes into PCR tubes,
ﬂash-frozen in liquid nitrogen and stored at 193 K (Deng et al., 2004).
For the circular dichroism and nuclear magnetic resonance spectro-
scopy experiments,
15N-labeled uncleaved Bh-MutT was prepared
from 1 l of autoinduction medium (Studier, 2005) and puriﬁed by a
conventional two-step protocol involving Ni- NTA afﬁnity chroma-
tography followed by size-exclusion chromatography using CD buffer
(100 mM NaCl, 20 mM Tris, 1.0 mM dithiothreitol, pH 7.1).
2.2. Nuclear magnetic resonance spectroscopy
A Varian 600-Inova spectrometer equipped with a
1H{
13C,
15N}
triple-resonance probe and pulse-ﬁeld gradients was used to collect a
2D
1H–
15N HSQC spectrum from
15N-labeled Bh-MutTin CD buffer
(293 K).
2.3. Circular dichroism spectroscopy
A calibrated Aviv Model 410 spectropolarimeter (Lakewood, New
Jersey, USA) was used to collect circular dichroism data from a
0.05 mM sample of Bh-MutT in CD buffer in a quartz cell of 0.1 cm
path length. Using the same sample, a thermal denaturation curve
was obtained by recording the ellipticity at 220 nm in 2.0 K intervals
from 283 to 353 K. A quantitative estimation of the melting
temperature, Tm, was obtained by taking the ﬁrst derivative of the
thermal denaturation curve (Greenﬁeld, 2006) using the Aviv soft-
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Figure 1
General chemical structure of a Nudix substrate: a Nucleotide diphosphate linked
to a moiety ‘x’. The moiety ‘x’ may be as small as a hydrogen atom or metal ion.ware. Steady-state wavelength spectra for Bh-MutTwere recorded in
0.5 nm increments between 200 and 260 nm at 298 K. The reported
steady-state wavelength spectrum was the result of averaging two
consecutive scans with a bandwidth of 1.0 nm and a time constant of
1.0 s. The spectrum was processed by subtracting a blank spectrum
from the protein spectrum and then automatically line-smoothing the
data using the Aviv software.
2.4. Crystallization
Sitting-drop vapor-diffusion crystallization trials were set up at
289 Kusing the Wizard full matrix (Emerald BioSystems, Bainbridge,
Washington, USA) or ProPlex sparse-matrix (Molecular Dimensions,
Newmarket, England) screens with or without in situ proteolysis with
chymotrypsin (0.01 mg ml
 1; Wernimont &Edwards, 2009).Bh-MutT
stock solutions (0.4 ml) were mixed with reservoir solution (0.4 ml)
and equilibrated against reservoir solution (100 ml) using 96-well
Compact Jr plates (Emerald BioSystems, Bainbridge, Washington,
USA). Crystals grew in several conditions, but those used in X-ray
data collection and structure determination were obtained from
ProPlex condition B5 without in situ proteolysis (27 mg ml
 1 protein
against 0.1 M HEPES, pH 7.5, 10% PEG 4000, 0.1 M MgCl2).
2.5. Data collection and structure refinement
A crystal of Bh-MutT was cryoprotected with reservoir solution
supplemented with 20% glycerol, ﬂash-frozen in liquid nitrogen,
stored under liquid nitrogen, and shipped to the Advanced Light
Source (ALS) at Lawrence Berkeley National Laboratory for X-ray
data collection. A data set was collected on ALS beamline 5.0.3 with
an ADSC Quantum 315 detector (Table 1) and reduced with XDS/
XSCALE (Kabsch, 2010). The structure was solved by molecular
replacement using Phaser (McCoy et al., 2007) from the CCP4 suite
(Winn et al., 2011) with the NMR solution structure of E. coli MutT
(PDB entry 1tum, ﬁrst model; Lin et al., 1997) as the search model
after alignment modiﬁcation in CHAINSAW (Stein, 2008). The
structure wasinitially rebuiltwith Buccaneer (Cowtan, 2006) followed
by additional model building in ARP/wARP (Langer et al., 2008).
The ﬁnal model was produced after numerous iterative rounds of
reﬁnement in REFMAC (Murshudov et al., 1997) and manual
building in Coot (Emsley & Cowtan, 2004). The ﬁnal model showed
good geometry and ﬁtness (Table 1) according to analysis with
MolProbity (Chen et al., 2010).
The amino-acid sequence of Bh-MutT deposited in the PDB is
numbered sequentially, Met1–Ile158, starting with the 21 non-native
residues that were part of the N-terminal polyhistidine tag. Here, the
ﬁrst native residue, Met22 in the PDB deposition, is labeled Met1.
3. Results and discussion
3.1. Structure of Bh-MutT
The crystal structure includes two molecules of Bh-MutT, A and B,
packed together in the asymmetric unit. Electron density was missing
at the N-terminus for the 21-residue tag plus the ﬁrst six native
residues in both subunits. At the C-terminus, electron density was
missing for the last two residues of subunit A and the last residue of
subunit B. The structure of each molecule in the asymmetric unit was
similar; the C
  atoms of residues Ser6–Phe135 of the two subunits
superposed with a root-mean-square deviation (r.m.s.d.) of 0.61 A ˚
(Winn et al., 2011). With a buried surface area of 11.4%, the
PDBePISAserver(http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html)
predicts the biological unit of the protein to be a dimer as shown in
Fig. 2. This observation in the crystalline state was also corroborated
in solution. Bh-MutT eluted from a Superdex75 size-exclusion
column with a retention time of 68 min, a value that is more consis-
tent with a 36 kDa dimer than an 18 kDa monomer (21-residue
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Table 1
Summary of the diffraction data-collection and reﬁnement statistics for Bh-MutT.
Value in parentheses are for the highest resolution shell.
Data collection
X-ray source ALS beamline 5.0.3
Detector ADSC Q315 CCD
X-ray wavelength (A ˚ ) 0.97946
Temperature (K) 100
Data set Native
Space group C2
Unit-cell parameters
a (A ˚ ) 96.50
b (A ˚ ) 93.49
c (A ˚ ) 43.88
  =   ( )9 0
  ( ) 109.24
Matthews coefﬁcient (A ˚ 3 Da
 1) 2.62
Solvent content (%) 53.12
Resolution range (A ˚ ) 50–2.1 (2.15–2.10)
Mean I/ (I) 12.71 (2.06)
No. of observed reﬂections† 21194 (1406)
Completeness (%) 98.4 (98.2)
Multiplicity 3.6 (2.6)
Rmerge‡ (%) 0.073 (0.488)
Rmeas§ (%) 0.086 (0.606)
Phasing
Molecular replacement model 1tum
Reﬁnement
No. of reﬂections used 20108
Rwork} (%) 20.2 (27.7)
Rfree†† (%) 23.4 (31.5)
Mean B factor (A ˚ 2) 30.5
R.m.s.d. bonds (A ˚ ) 0.014
R.m.s.d. angles ( ) 1.391
Model validation
MolProbity Ramachandran analysis
Most favored (%) 98
Additionally allowed (%) 2
MolProbity
Clash score, all atoms [percentile] 7.59 [94th]
MolProbity score [percentile] 1.82 [90th]
† All reﬂections were used in data reduction. ‡ Rmerge =
P
h
P
i jIiðhÞ h IðhÞij= P
h
P
i IiðhÞ.§ Rmeas =
P
hkl½N=ðN   1Þ 
1=2 P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ
(Diederichs & Karplus, 1997). } Rwork =
P
hkl
   jFobsj j Fcalcj
   =
P
hkl jFobsj, where Fobs
and Fcalc are the observed and calculated structure factors, respectively, calculated with
the 95% of the reﬂections remaining after setting aside 5% for Rfree.† † Rfree = P
hkl
   jFobsj j Fcalcj
   =
P
hkl jFobsj. The free R factor was calculated using 5% (1086) of the
reﬂections, which were omitted from the reﬁnement.
Figure 2
A transparent surface representation of the two subunits in the asymmetric unit of
the crystal structure of Bh-MutT (PDB entry 3hhj). A cartoon representation of the
structure is illustrated underneath the surface. The two subunits are colored cyan
and purple and the Mg
2+ ions are colored yellow.N-terminal tag present). Furthermore, the
1H–
15N HSQC spectrum of
uncleaved
15N-labeled Bh-MutT featured broad cross-peaks char-
acteristic of a protein much larger than 18 kDa (data not shown).
Dimeric Nudix hydrolases have previously been observed both in
solution and in the crystalline state and are sometimes required for
the Nudix hydrolase to function optimally (Wang, Mura et al., 2002).
Fig. 3(a) shows a cartoon representation of the structure of
Bh-MutT and Fig. 3(b) shows a two-dimensional schematic of the
individual secondary structure components. The molecule is com-
posed of six  -strands organized into two  -sheets, two  -helices and
two 310-helices. Four of the  -strands form the core of the Nudix fold,
a mixed  -sheet with the central two  -strands parallel to each other,
sandwiched between the catalytic helix ( 1) and an orthogonally
orientated C-terminal helix ( 2). Such an arrangement is observed in
Nudix proteins of known structure (Mildvan et al., 2005; McLennan,
2006).
Nudix proteins are all characterized by the presence of a highly
conserved 23-residue ‘Nudix box’, GX5EX7REUXEEXGU, where U
is a bulky hydrophobic group and X is any residue (Abeygunawar-
dana et al., 1995; Bessman et al., 1996). The Nudix sequence adopts a
loop–helix–loop motif (Koonin, 1993) that serves to coordinate the
catalytically essential divalent cation (usually Mg
2+) to the protein
(Lin et al., 1997; Bailey et al., 2002; Gabelli et al., 2001). Nine of the
23 residues in the Nudix box are highly conserved, G
42X5E
48X7R
56-
E
57L
58XE
60E
61XG
63V
64 (bold, with the superscripts referring to the
residue numbers in the Bh-MutT sequence), and Fig. 4(a) illustrates
the relative orientation of these highly conserved residues in the
loop–helix–loop Nudix motif of Bh-MutT. As observed in other
Nudix structures, all of the polar conserved residues in the  -helix of
Bh-MutTare orientated on the same side and are opposite the central
mixed  -sheet. A small hydrophobic pocket formed by the side chains
of Leu58 and Val64 is likely to play a conserved role in stabilizing
the loop–helix–loop Nudix motif. The similar three-dimensional
orientations of the conserved residues in the Nudix box of all known
Nudix protein structures suggest that these residues play similar roles
in all Nudix hydrolases, binding one or more divalent cations (Wang,
Mura et al., 2002). This is true for Bh-MutT, as shown in the electron-
density map in Fig. 4(b), in which the hydroxyl groups of Glu57
and Glu61 are near the Mg
2+ ion at distances of 2.10 and 2.11 A ˚ ,
respectively, which are within the expected Mg
2+-coordination
distance range (Zheng et al., 2008). It has been established that
binding of the catalytic divalent metal ion occurs through the side
chains of the glutamic acid residues in the loop–helix–loop Nudix
motif (Lin et al., 1997; Bailey et al., 2002; Gabelli et al., 2001; Buchko
et al., 2008). The bound metal in turn complexes with the diphosphate
part of the substrate (Fig.1) and forms part of the enzyme’sactive site
(Lin et al., 1997). Diphosphate interactions with both the loop–helix–
loop Nudix motif and the divalent metal cation are features that are
common to all Nudix proteins. The other parts of the Nudix substrate,
the nucleoside and the moiety ‘x’, interact with the side chains and
motifs elsewhere in the protein (Lin et al., 1997; Gabelli et al., 2001;
Bailey et al., 2002; Massiah et al., 2003; Mildvan et al., 2005). Differ-
ences in the shape and nature of the environment surrounding the
Nudix box are responsible for the different substrate speciﬁcities of
different Nudix hydrolases and some of the structural differences
between Nudix hydrolases (Ranatunga et al., 2004).
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Figure 3
(a) Cartoon representation of the crystal structure of Bh-MutT in the Mg
2+-bound state (PDB entry 3hhj). The  -strands are colored blue,  -helices red and 310-helices
magenta. The 23-residue ‘Nudix box’ consists of residues Gly42–Val64. (b) Secondary-structure diagram of Bh-MutT. The  -helices are drawn as red ovals and 310-helices as
magenta ovals, with the residue number of the beginning and the end of each element shown. The  -strands are drawn as solid blue arrows with each residue indicated within
a box. The  -sheets contain a bulge at residue Pro73. A solid pink line between  -strand residues indicates dual hydrogen bonds between two residues in an antiparallel
 -sheet. The regions between secondary-structure elements (black lines) are not drawn to scale.3.2. Circular dichroism profile and thermal stability of Bh-MutT
Circular dichroism spectroscopy is sensitive to small changes in
a protein’s backbone and consequently it is a useful tool to quickly
probe the conformation of proteins in solution and assess the effect
of variables on a protein’s structure (Woody, 1974). Fig. 5(a) shows
the steady-state CD spectrum for Bh-MutT collected at 298 K. The
dominant feature of the spectrum is characteristic of an  -helical
secondary structure: a double minimum at approximately 222 and
208 nm and an extrapolated maximum around 195 nm (Holzwarth &
Doty, 1965; Greenﬁeld, 2006). Note that the double minimum is
skewed and more intense around 220 nm, which is likely to be a
consequence of the contribution of other secondary-structure
elements to the CD steady-state spectrum.
Usually, the ellipticity at a speciﬁc wavelength increases with
increasing temperature as the protein unfolds and a melting tem-
perature, Tm, may be estimated for the transition between a struc-
tured and an unstructured state (Karantzeni et al., 2003). However, it
has recently been observed that the thermal melt for the Nudix
hydrolase DR_0079 from the bacterium Deinococcus radiodurans
displays the opposite behavior, suggesting an increase in ordered
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Figure 5
(a) Circular dichroism steady-state wavelength spectrum for Bh-MutT (0.05 mM) in CD buffer collected at 298 K. (b) The CD thermal melt for Bh-MutT obtained by
measuring the ellipticity at 220 nm in 2.0 K intervals between 283 and 353 K. (c) The ﬁrst derivative of the thermal melt curve shows that the protein has a melting
temperature of 333 K.
Figure 4
(a) Cartoon representation of the crystal structure of Bh-MutTwith the 23-residue Nudix box highlighted in wheat. The side chains of the residues that form the Nudix box
are shown (O, red; N, blue) along with the Mg
2+ ion (black sphere). (b) The electron density surrounding the Mg
2+ ion in the crystal structure of Bh-MutTillustrated at 1.2 .
The O atoms from the side chains of Glu61 and Glu57 are coordinated to the ion.structure with an increase in temperature (Buchko, 2010). To probe
whether this unusual temperature effect observed for DR_0079 is
more widespread in Nudix hydrolases, a melting temperature was
determined for Bh-MutT. As shown in Fig. 5(b), the melting proﬁle
was typical. A gradual increase in ellipticity at 220 nm was observed
for Bh-MutT up to  323 K, followed by a more rapid increase in
ellipticity that leveled off at  335 K. Visual inspection of the sample
after heating to 353 K showed evidence of precipitation, indicating
that the unfolding was irreversible, and consequently the CD data
could not be analyzed thermodynamically (Karantzeni et al., 2003). A
quantitative estimation of the Tm for this transition was still possible
by assuming a two-state model and taking a ﬁrst derivative of the
curve in Fig. 5(b) (Greenﬁeld, 2006). The maximum of this ﬁrst
derivative, shown in Fig. 5(c), is 333 K.
4. Conclusions
The crystal structure of Bh-MutT is similar to the structures reported
for other Nudix hydrolases. The  -helix of the highly conserved
Nudix box in Bh-MutT is one of two helices that sandwich a four-
stranded mixed  -sheet with the central two  -strands parallel to each
other. The structure was determined in the metal-bound form, with
the catalytically essential divalent cation Mg
2+ observed to be co-
ordinated to the side chains of Glu57 and Glu61. While the crystal
structure of Bh-MutT is similar to those of other Nudix hydrolases,
these enzymes act on a wide range of substrates. The structural
diversity that surrounds the basic Nudix box structure confers the
functional diversity of Nudix hydrolases (Ranatunga et al., 2004;
Mildvan et al., 2005; McLennan, 2006). The next step in under-
standing the cellular biochemical role of Bh-MutT in B. henselae is to
equate the enzymatic activity of Bh-MutT to speciﬁc Nudix substrates
(Ranatunga et al., 2004; Buchko et al., 2008). Such information,
together with the structure provided here for Bh-MutT, will make it
possible to better correlate Nudix sequences and structures with
speciﬁc substrates and facilitate rational structure-based drug design
targeting B. henselae.
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